Method and kit for separation of glycoproteins

• US 4,269,605 A
• Filed: 06/27/1979
• Issued: 05/26/1981
• Est. Priority Date: 06/28/1978
• Status: Expired due to Term

• Current Assignee: W R Grace & Company - CONN (WR Grace & Company)
• Original Assignee: Amicon Corporation (Merck & Co., Inc.)
• Inventors: Dean, Peter D. G., Brown, Peter J., Bouriotis, Vasilis
• Primary Examiner(s): Turk, Arnold
• Application Number:
  US06/052,474
• Time in Patent Office: 699 Days
• Field of Search: 23/230 B, 23/913, 23/901, 422/61, 260/112 R, 260/112 B
• US Class Current: 436/67
• CPC Class Codes: C07K 14/47 from mammals
• CPC Class Codes: C07K 14/805 Haemoglobins; Myoglobins
• CPC Class Codes: G01N 33/723 Glycosylated haemoglobin
• CPC Class Codes: Y10S 530/816 Attached to the carrier via a bridging agent

Abstract

Glycoproteins, especially glycosylated hemoglobins, are separated from non-glycosylated proteins, by complexing with a dihydroxyboryl reactive agent. The resulting complex can be separated physically from the non-glycosylated protein, making possible the determination of glycosylated hemoglobin content of lysed blood; a reactive agent and a kit are described for use in such determination and as a monitor in the control of diabetic treatment. The invention can also be used preparatively to isolate glycoproteins.

Claims

1. The method of separating glycoproteins from nonglycosylated proteins in a mixture which comprises bringing said mixture into contact with reactive agent comprising a dihydroxyboryl group bonded to a support to form a glycoprotein-dihydroxyboryl complex, and separating said complex from said mixture.

2. The method as claimed in claim 1 in which said dihydroxyboryl group is covalently bonded to said support.

3. The method as claimed in claim 2 in which said glycoprotein is glycosylated hemoglobin.

4. The method of assaying blood for glycosylated hemoglobin which comprises lysing a sample of blood, separating cellular debris from said lysed sample, buffering said lysed sample to a pH in the range between about 7.5 and 9.0, bringing said lysed sample into contact with a selective agent comprising a dihydroxyboryl group covalently bonded to an agarose support to form a complex of said dihydroxyboryl group with glycosylated hemoglobin in said sample, separating said complex from said sample, and determining the amount of glycosylated hemoglobin in said complex.

5. The method as claimed in claim 4 in which the amount of glycosylated hemoglobin is determined colorimetrically.

6. A kit for assaying the glycosylated hemoglobin content of a blood sample comprising as components (1) a reactive agent for glycosylated hemoglobin comprising a dihydroxyboryl group bonded to a support, (2) a buffer capable of maintaining the pH of said sample of blood at a value in the range between about 7.5 and 9.0, and (3) a supply of lysing agent for lysing said blood sample.

7. A kit as claimed in claim 6 in which said support comprises agarose in finely divided form and said dihydroxyboryl group is covalently bonded thereto.

8. A kit as claimed in claim 7 in which said dihydroxyboryl group is covalently bonded to said agarose by reacting said agarose with an aliphatic diepoxide having 3 to 6 carbon atoms and with an aminophenylboronic acid.